Synonym:
22,23-Dihydroavermectin B1,
MK-933
Properties:
Related Categories |
Analytical Standards,
Analytical/Chromatography,
Antibiotics,
Antibiotics A to Z,
Antibiotics G-M,
|
InChI Key
|
AZSNMRSAGSSBNP-XPNPUAGNSA-N
|
form
|
powder
|
solubility
|
MEK: 50 mg/mL
|
originator
|
Merck Sharp & Dohme
|
storage temp.
|
2-8°C
|
Gene Information
|
human ... ABCB1(5243), CYP3A4(1576) mouse ... Abcb1a(18671), Abcb1b(18669)
|
Description:
Frequently Asked Questions
Frequently Asked Questions
are available for this Product.
Other Notes
Primarily ivermectin B1a.
Packaging
1 g in poly bottle
250 mg in poly bottle
Biochem/physiol Actions
Positive allosteric modulator of α7 neuronal nicotinic acetylcholine receptor; also modulates glutamate-GABA-activated chloride channels.
Features and Benefits
This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC®1280), a biologically annotated collection of high-quality, ready-to-screen compounds. Click here to learn more.
This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Merck. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
LOPAC is a registered trademark of Sigma-Aldrich Co. LLC
Safety:
Symbol


GHS06, GHS08
Hazard statements
H300-H351-H360D
Precautionary statements
P201-P264-P281-P301 + P310-P308 + P313
Personal Protective Equipment
Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
RIDADR
UN 2811 6.1 / PGII